Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Waylivra (volanesorsen) 285 mg solution for injection in pre-filled syringe {equilateral_black_triangle}

Active Ingredient:
volanesorsen sodium
Akcea Therapeutics UK Ltd See contact details
ATC code: 
About Medicine
Akcea Therapeutics UK Ltd
Company image
1st Floor West, Davidson House, Forbury Square, Reading, Berkshire, RG1 3EU, UK
Medical Information Direct Line
+44 (0) 800 111 4754
Medical Information e-mail
[email protected]